初代和继代培养葡萄试管苗的内源nA、ZRs和ABA含量变化及其与生根的关系

葡萄品种皇家秋天与藤稔初代试管苗在第10天(根原基发生)时内源IAA和ABA含量达最低点后上升;ZRs含量达最高值后下降。皇家秋天继代试管苗的IAA在第8天(根原基发生)时达最低点,而后上升达稳定4／t;ZRs含量达最高值后下降;ABA含量降至最低点后急剧上升,在第10天(生根时)达最高值,持续4d后又下降。藤稔继代苗在第6天(根原基发生)时IAA含量最低,后上升,持续到第12天后又下降;ZRs含量达最高值后快速下降,至第12天达稳定状态;ABA含量达最低值后缓慢上升,第10天(生根)达最高点后又下降。     

继代培养次数对杜梨生根能力和叶形态及其激素水平的影响

为了探索杜梨组培复幼变化规律,对10年生杜梨进行连续继代培养,统计不同继代次数杜梨丛生芽繁殖系数和生根率,观察记录叶片形态变化并测定内源激素含量。结果表明:(1)通过连续继代培养,杜梨丛生芽生根率由0提升到66.70%,繁殖系数由第1代的2.13提升到第10代的4.20。(2)叶片在继代第3次时出现裂刻且随后裂刻程度逐代加深;在继代过程中,丛生芽叶面积和叶脉数显著降低,叶周长和叶形指数呈先下降后上升的变化趋势。(3)丛生芽叶片内源IAA含量在继代第6次时达到46.39 ng·g-1,且显著高于初代丛生芽;随着继代次数的增加,叶片内源ZR呈先上升后下降的变化趋势,内源GA3含量没有发生显著性变化,而内源ABA含量逐渐降低;叶片IAA/ABA和IAA/ZR的值随着继代次数的增加而增加。(4)丛生芽叶片ABA含量和IAA/ZR与其生根率分别呈显著负相关和显著正相关关系,叶片裂刻数和IAA/ABA与生根率均呈现极显著正相关关系,而叶脉数与生根率则呈现极显著负相关关系。研究认为,连续继代培养可显著提高杜梨丛生芽的生根能力,并且与丛生芽叶形和激素含量及其比值有密切的关系,该研究结果为难生根植物无性繁殖以及树木复幼提供了重要技术借鉴。     

无花果花芽分化与内源激素含量的关系

在‘布兰瑞克’无花果花芽分化形态学研究的基础上,对花芽分化期无花果新梢第7或第8节位花芽中的玉米素核苷(ZRs)、脱落酸(ABA)、赤霉素(GA1 3)、生长素(IAA)4种内源激素含量的变化进行了探讨。结果表明,在无花果花芽分化阶段,GA1 3和IAA初期含量较高,后快速下降,后期稳定在较低水平;ZRs和ABA在初期含量较低,后大幅提高,后期稳定在较高水平。可见,较高水平的内源ZRs、ABA和较低水平的内源GA1 3、IAA,以及较高的ABA/IAA、ABA/GA1 3、ZRs/GA1 3和ZRs/IAA比值有利于无花果花芽分化。     

内源吲哚乙酸、脱落酸和赤霉酸与棉铃发育及脱落的关系

气相色谱分析的结果表明,开花后5～6天,不受精即将脱落棉铃里IAA和ABA的含量显著高于对照;GA_3处理的铃中IAA和ABA的含量则明显低于对照。IAA和GA_3含量在开花后第10天达到高峰,以后迅速下降,至第30天。又出现第二峰胚珠和纤维里尤为明显。ABA含量在开花后第15天达得高峰,以后下降,到第30天,又逐渐上升。棉纤维伸长及干重增加的最快速率与这三种激素的含量高峰密切相关。     

葡萄试管苗生根与体内金属离子含量变化

"矢芙罗莎"、"森田尼无核"、"藤稔"和"皇家秋天"4种葡萄试管苗开始生根时,Cu2 、Zn2 、Fe2 和Ca2 含量增加,而后下降,维持较低水平;Mg2 含量先下降,以后则上升至正常水平.     

IBA和NAA对山杜英组培苗生根过程中内源IAA、ABA含量变化的影响

本文研究山杜英组培苗生根过程中内源IAA、ABA含量变化规律。结果表明,培养基添加IBA和NAA后,在生根过程中内源IAA、ABA含量变化类似,根点出现前内源IAA、ABA含量一直上升,根点出现后含量开始下降,产生愈伤组织时两种处理的IAA/ABA分别是2.526和3.226。在不添加外源生长素情况下,内源IAA含量一直维持在较低水平,而内源ABA含量一直呈现上升趋势,IAA/ABA始终都在1.211以下。     

雷公藤离体快繁过程中内源激素水平的变化

对雷公藤Tripterygium wilfordii组培苗各生长发育阶段的内源激素变化进行研究。结果表明,在芽诱导过程中,培养7～14 d是芽诱导的关键性阶段,ZT含量呈上升趋势,在培养28～35 d时,ABA含量转为上升,芽体生长进入缓慢抑制阶段;在芽继代增殖过程中,GA3含量升高,ABA含量降低,GA3/IAA比值高及ABA/IAA比值低利于雷公藤芽体分化增殖;在壮苗培养过程中,IAA、GA3含量上升,但两者浓度过高或过低均不利于生长;生根培养第7 天,雷公藤根系开始生成,IAA含量达到一峰值,在生根初期,低比值ZT/IAA及高比值GA3/ABA利于雷公藤生根培养。     

水培紫花苜蓿的茎段生根过程中内源激素含量变化

检测水培紫花苜蓿茎段生根过程中赤霉素（GA3）、生长素（IAA）和脱落酸（ABA）含量变化的结果表明：离体茎段中,GA3、IAA和ABA含量大幅度下降。愈伤组织形成前期ABA含量达到一个较高值。愈伤组织和不定根形成时期,GA3含量保持较低水平;IAA含量上升,生根期达到最大;ABA含量下降。生根后,GA3含量仍保持较低水平;IAA含量迅速下降;ABA含量迅速上升。     

枣花芽分化过程中营养物质和内源激素含量及抗氧化酶活性变化研究

以新疆主栽品种灰枣和骏枣的花芽为材料,测定不同分化时期花芽的可溶性糖、还原糖、淀粉、可溶性蛋白含量,SOD、POD、PPO、CAT活性以及内源GA₃、IAA、ABA、ZT水平的变化,并分析它们与花芽分化的关系,为枣花芽分化调控提供理论参考。结果表明:(1)灰枣和骏枣花芽可溶性糖、还原糖和淀粉含量在花芽分化过程的变化趋势基本相似,于花原基分化期至雌蕊分化期先降低后升高,至雌蕊分化期到达峰值;而可溶性蛋白质含量变化趋势相反,在花原基分化期至雌蕊分化期先上升再降低。(2)在整个花芽分化过程中,其POD、PPO、CAT活性变化趋势基本一致,从花芽开始分化后逐步降低,最低点出现在雌蕊分化期;两个品种花芽SOD活性在花原基分化期至分化初期时显著上升,之后SOD活性在灰枣中不断降低,而在骏枣中则显著上升。(3)两品种花芽IAA、GA₃、ZT含量在分化过程中的变化规律基本相似,它们均在萼片分化期前呈下降趋势,之后GA₃、ZT含量及灰枣中IAA含量逐渐上升,而骏枣IAA含量在萼片分化期至花瓣分化期呈先显著上升后下降再上升;灰枣ABA含量在花原基分化期至萼片分化期显著上升,而同期骏枣则显著降低,随着分化进程的推进,灰枣ABA含量在萼片分化期后逐步降低,而骏枣则逐步上升并在雌蕊分化期达到峰值。(4)花芽分化开始后,骏枣ABA/IAA、ZT/IAA、GA₃/IAA比值快速上升,但GA₃/ABA、ZT/ABA的比值呈下降趋势;灰枣ZT/IAA、GA₃/IAA在花原基分化期至萼片分化期显著上升后降低,分化结束后低于花原基分化期。研究认为,枣花芽开始分化后会消耗大量的营养物质,导致花芽的可溶性糖、淀粉和还原糖含量降低,且整个分化过程中淀粉含量始终高于可溶性糖和还原糖含量;两个品种枣花芽分化过程中POD、CAT、PPO活性下降以及骏枣花芽分化过程中SOD活性的上升均有利于枣营养生长向生殖生长的转变,且枣花芽分化过程中低水平的GA₃和IAA、中等水平的ABA、较高水平的ZT,以及较高的ZT/IAA、ABA/IAA和GA₃/IAA有利于枣花芽分化和花芽形成。     

离体黄瓜子叶节花芽分化与内源激素及多胺的关系

用高效液相色谱法(HPLC)测定了黄瓜子叶节花芽分化期(0-6天)内源激素及多胺的变化。结果显示,子叶培养0-2天生长素(IAA)、赤霉素(GA_3)、玉米素(ZT)、脱落酸(ABA)等4种内源激素均明显下降,4-5天略有上升,表明0-2天IAA、GA_3和ABA的剧降有利于花原基形成,3-5天较高的ZT含量有利于花器官原基的形成。除腐胺(Put)外,精胺(Spm)、亚精胺(Spd)、尸胺(Cad)在0-1天均下降,1-4天上升,4-5天再下降,Put在0-1天急剧上升,而后持续下降,表明高水平的内源多胺总量和Put可能有利于花原基分化,2天后Spm含量上升有利于花器官原基分化,而Cad含量变化可能是区别花芽和营养芽分化的特征之一。     

Race and Racism in America and in Anthropology

Race in North America: Origin and Evolution of a Worldview . Audrey Smedley
Anthropology and Race . Eugenia Shanklin     

Degradation and conversion of somatostatin in normal and diabetic rats in vivo and in vitro

Plasma somatostatin-like immunoreactivity in the portal and jugular veins of streptozotocin diabetic rats was compared with that in normal control rats. In the diabetic group, somatostatin levels in the portal (p less than 0.05) and jugular (p less than 0.01) veins were both elevated compared with those in the control group. Moreover, the degree of elevation was greater in the jugular vein than in the portal vein. To further investigate the role of the liver in the clearance of somatostatin-28 in vivo, 2 micrograms of somatostatin-28 was administered as a bolus into the external jugular vein of intact and functionally hepatectomized rats. The mean half-time of somatostatin-28 was significantly longer in intact diabetic rats than in controls (p less than 0.05). The functional hepatectomy did not cause a significant difference in the half-time in diabetic rats but made it longer in control rats. These results suggest that the longer half-time of somatostatin-28 in diabetic rats in vivo is due to its slower hepatic clearance. The hepatic clearance of somatostatin-28 and somatostatin-14 was further studied in vitro using a recirculating liver perfusion method. The hepatic clearance of 1.2 nM of either somatostatin-28 or somatostatin-14 was significantly lower in diabetic rats than in controls (p less than 0.01). This indicates that elevated plasma somatostatin levels in diabetic rats are caused at least in part by decreased hepatic clearance of somatostatin.(ABSTRACT TRUNCATED AT 250 WORDS)     

Deoxynivalenol and nivalenol in wheat and by-products in Argentina

The deoxynivalenol and nivalenol contamination in wheat and by-products obtained through milling was analized by Trucksess method slightly modified in the proportion of acetonitrile—water (3:1). Only one sample of wheat showed deoxynivalenol contamination, 1,200μg/kg. No samples obtained in different stages of the milling were contaminated with deoxynivalenol or nivalenol. In the commercial wheat flours the levels found ranged between 400 and 800μg/kg, as follows: 400μ/kg, 5 samples; 800jug/kg, 1 sample.     

Obestatin and ghrelin in obese and in pregnant women

We identified, through qPCR, receptor mRNA for a number of gut peptides in female human omental fat: the incretins, GIP and GLP-1, the orexigenic peptides PYY-Y1 and -Y2 and ghrelin, and the anorexigenic peptide obestatin. Four cohorts of women were examined: lean controls (BMI<23), obese (BMI>41), obese diabetic and term pregnant women. Human fat expressed receptor mRNAs for all six peptides. Pregnant women expressed roughly three times as much orphan GPR-39 receptor, a proposed obestatin receptor, than other women and less than half as much of the ghrelin receptor (GHSR-1a). An immunoblot probed with a GPR-39 selective antibody yielded a single band corresponding to the correct molecular weight (52 kDa) for the proposed obestatin receptor. Fluorescent immunohistochemistry of human fat employing the same antibody indicated the receptor protein was localized to the adipocyte cell membrane. The concentration of obestatin circulating in blood was measured in the same cohort of women and was significantly lower in obese and obese diabetic women compared to control.     

Update in research and methods in proteomics and bioinformatics

The 3rd International Conference on Proteomics & Bioinformatics (Proteomics 2013)

Philadelphia, PA, USA, 15–17 July 2013

The Third International Conference on Proteomics & Bioinformatics (Proteomics 2013) was sponsored by the OMICS group and was organized in order to strengthen the future of proteomics science by bringing together professionals, researchers and scholars from leading universities across the globe. The main topics of this conference included the integration of novel platforms in data analysis, the use of a systems biology approach, different novel mass spectrometry platforms and biomarker discovery methods. The conference was divided into proteomic methods and research interests. Among these two categories, interactions between methods in proteomics and bioinformatics, as well as other research methodologies, were discussed. Exceptional topics from the keynote forum, oral presentations and the poster session have been highlighted. The topics range from new techniques for analyzing proteomics data, to new models designed to help better understand genetic variations to the differences in the salivary proteomes of HIV-infected patients.